āshibio creates treatments for rare bone and connective tissue ailments, potentially preventing symptoms or slowing their course.

Gate Bioscience specializes in a small molecule modality to treat biology’s intractable diseases.

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

SchoolCare delivers free health technology for K-12 public schools to help school nurses deliver care and keep students safe. It is a digital health platform for the largest and most consistent health delivery system in the country. Their mission is to work with partners to provide a unified health record for every family. SchoolCare leverages pediatric health data and this country’s most successful public health organization, the K-12 school system, to improve outcomes and learn about clinical health data outside of the provider’s office. Traditional care coordination stops short of sending essential care instructions to School Nurses and thus increases the risk of stopped or inconsistent post-discharge care delivery. By closing the link in the pediatric care continuum, children stay healthy and get better faster.

Inxeption Corporation provides software solution. The Company offers e-commerce platform to promote, sell, and manage consumer products. Inxeption serves customers internationally.

Myovant Sciences Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing innovative therapies for women's health diseases and other endocrine-related disorders. Myovant Sciences develops relugolix for the treatment of heavy menstrual bleeding associated with uterine fibroids and endometriosis-associated pain.

Caption Health will use this funding to scale up its commercial operations, continue to develop its AI technology platform and form new partnerships. As more providers adopt the Caption AI platform, the company plans to add new clinical capabilities to expand the use of Caption AI in additional care settings.

Trove builds technology that allows brands to take control of their resale marketplaces, deepening customer loyalty and generating new profits. The company provides white-label technology and end-to-end operations that power circular shopping for premium and luxury brands such as Levi’s, Patagonia, lululemon, REI, Eileen Fisher, and Arc’teryx. Trove enables brands to take back items from customers’ closets while maintaining control of their brand equity and owning their customer experience, data and relationships. Rooted in a commitment to sustainability, Trove aims to create a world where all consumers have access to better products with less waste.

Yerdle’s end-to-end technology and logistics platform provides a white label solution for brands ready to take back their secondary market from emerging online competitors. Yerdle empowers brands to reach new customers and deepen existing relationships —while developing more sustainable, circular business practices. Yerdle Recommerce began as a used goods marketplace, helping 950,000 members share more than 1.2 million items, from jackets to tents. Today, Yerdle Recommerce is proud to support iconic brands such as Patagonia, REI, and Eileen Fisher in their efforts to develop new business models that deepen customer engagement.

Aimmune Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing treatments to protect children with food allergies from accidental exposure. Aimmune Therapeutics serves customers in the United States.

Keystone Strategy offers economics, data analysis, product development, intellectual property, and antitrust making it ideal for developing bold strategies with far-reaching implications for business, consumers, and public policy. Their diverse teams draw on expertise in business, technology, and economics. Their expertise includes digital transformation, innovation, artificial intelligence, machine learning, data analytics, algorithms, ecosystem strategy, process optimization, antitrust, intellectual property, and tax transfer.

CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company aims to transform long-term patient care in transplantation by offering novel surveillance management solutions.